Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,002
Closed -$1.49M 4648
2025
Q4
$1.49M Buy
+20,002
New +$1.46M ﹤0.01% 2107
2025
Q3
Sell
-1,825
Closed -$121K 4767
2025
Q2
$119K Sell
1,825
-692
-27% -$41.5K ﹤0.01% 3692
2025
Q1
$155K Sell
2,517
-33,183
-93% -$2.2M ﹤0.01% 3421
2024
Q4
$2.57M Buy
35,700
+34,704
+3,484% +$2.71M 0.01% 1552
2024
Q3
$81.1K Sell
996
-737
-43% -$58.9K ﹤0.01% 4479
2024
Q2
$129K Buy
1,733
+432
+33% +$32.4K ﹤0.01% 4582
2024
Q1
$101K Sell
1,301
-6,270
-83% -$466K ﹤0.01% 4389
2023
Q4
$541K Sell
7,571
-4,083
-35% -$284K ﹤0.01% 2889
2023
Q3
$809K Buy
11,654
+7,319
+169% +$553K ﹤0.01% 2433
2023
Q2
$351K Buy
4,335
+4,115
+1,870% +$336K ﹤0.01% 2675
2023
Q1
$17.8K Buy
+220
New +$17.7K ﹤0.01% 3426
2022
Q2
Sell
-3,442
Closed -$264K 2517
2022
Q1
$264K Buy
+3,442
New +$248K 0.01% 1379
2020
Q4
Sell
-5,474
Closed -$364K 1005
2020
Q3
$364K Buy
+5,474
New +$346K 0.04% 462
2020
Q1
Sell
-3,900
Closed -$203K 1242
2019
Q4
$203K Buy
+3,900
New +$194K 0.01% 1104

Other funds holding HOLX

Walleye Capital's HOLX Position: Q1 2026 in Review

Walleye Capital sold out of Hologic (HOLX) in Q1 2026, closing a stake of 20,002 shares — an estimated $1.49M sold.

Walleye Capital first reported a position in HOLX in Q4 2019 and held it in 14 quarters. The position peaked at $2.57M in Q4 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Walleye Capital reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 20,002 Hologic shares in Q1 2026, an estimated $1.49M.
  • Walleye Capital first reported a position in Hologic in Q4 2019 and held it in 14 quarters.
  • Walleye Capital's Hologic position peaked at $2.57M in Q4 2024.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.